Compound Detail
CHEMBL5183525
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5183525 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZJPRHECZJLPOIQ-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
2
PK Parameters
3
Publications
0
Known Names
Molecular Properties
442.4
MW (Da)
5.08
ALogP
4
HBA
1
HBD
62.7
PSA (Ų)
0.60
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Ceramide glucosyltransferase CHEMBL2063 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 40.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.g-1 | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Ceramide glucosyltransferase | IC50 | = | 13.0 | nM | 7.89 | Inhibition of human GCS using C8-ceramide and UDP-glucose as substrate incubated... | 36341811 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36341811 | 10.1016/j.bmcl.2022.129039 | ADMET | 3 |
| 36341811 | 10.1016/j.bmcl.2022.129039 | No relevant target | 2 |
| 36341811 | 10.1016/j.bmcl.2022.129039 | Ceramide glucosyltransferase | 1 |
Data from ChEMBL 36 via Core Engine